Mangoceuticals

Update in progress

MGRX (NasdaqCM)

Company RatingNeutral
SectorHealthcare
IndustryHealth Information Services

Mangoceuticals, Inc. develops, markets, and sells men’s wellness products through a U.S. telemedicine platform. It offers Mango erectile dysfunction products, Grow hair loss products, Mojo hormone balance products, and Slim weight loss products. It provides oral testosterone undecanoate for low testosterone under Prime, plus access to a licensed online pharmacy for prescribed meds. Online at MangoRX.com. Based in Dallas, Texas since 2021, a subsidiary of Cohen Enterprises, Inc.

Company score

Sentiment: -0.01; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.13; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.06; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.02; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.01; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive